After adipocytes are reprogrammed into cancer-associated adipocytes by an EOC-derived mediator, these activated adipocytes can release various adipokines, such as IL-6, IL-8, MCP-1, and TIMP-1 that contribute to building the omental metastatic niche for EOC. The gene discussed is CCL2; the disease is cancer.